ArticleCancer2019
Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
Remington L NevinPubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it